Cleared Traditional

K915168 - PROFLEX 5

K915168 is an FDA 510(k) clearance for PROFLEX 5, manufactured by Peripheral Systems Group. The device is a Class 2 Cardiovascular device with product code LIT cleared through the Traditional 510(k) pathway after a 96-day FDA review.

K915168 · Peripheral Systems Group · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1992
Decision
96d
Days
Class 2
Risk

K915168 is an FDA 510(k) clearance for the PROFLEX 5. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by Peripheral Systems Group (Mountain View, US). The FDA issued a Cleared decision on February 19, 1992 after a review of 96 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Peripheral Systems Group devices

FDA 510(k) Submission Details - K915168

510(k) Number K915168 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 15, 1991
Decision Date February 19, 1992
Days to Decision 96 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
29d faster than avg
Panel avg: 125d · This submission: 96d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LIT Device Classification - Class 2, Special Controls

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 262
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K915168.
SCIMED SIDEWINDER TUOHY-BORST Y-ADAPTER
K921577 · Scimed Life Systems, Inc. · Oct 1992
STEALTH DILATION CATHETER SYSTEM (MODIFIED)
K915895 · Target Therapeutics · Jun 1992
ULTRA-THIN
K920547 · Boston Scientific Corp · May 1992
OPTI-PLAST 5F PTA CATHETERS, MODIFICATION
K914976 · Vas-Cath, Inc. · Jan 1992
OPTI-PLAST 5F PTA CATHETERS, MODIFICATION
K914500 · Vas-Cath, Inc. · Dec 1991
TEGWIRE (TM)
K913391 · Boston Scientific Corp · Nov 1991